BioGaia invests further in MetaboGen
On April 6, 2018, BioGaia became the majority shareholder in MetaboGen with a
62 percent stake. BioGaia has now, after the set mile (...) Read the full story
News
Latest news from Metabogen
BioGaia continues to invest in MetaboGen
On April 6 2018, BioGaia announced its decision to acquire additional shares in MetaboGen and is now investing SEK 11.7 million in shares (...) Read the full story
MetaboGen is granted US diabetes patent
MetaboGen AB has on January 30th, 2018 been granted a US patent for the identification of a person at risk for developing type 2 diabetes (...) Read the full story
Gravid med erfarenhet av graviditetsklåda?
Just nu pågår en forskningsstudie i Skåne och Stockholm för att undersöka bakgrunden till graviditetsklåda och om bakteriefloran i (...) Read the full story
MetaboGen and BioGaia initiates program for microbiome restoration
Today, MetaboGen and BioGaia have agreed to initiate a new development program addressing restoration of the microbiome after antibiotic (...) Read the full story
Jens Nielsen on the list of the world´s most-cited scientists
Web of Science has just published its list of the world’s most-cited researchers. The list includes, for the third year in a row, Metab (...) Read the full story
MetaboGen AB receives 4.9 MSEK for development of pharmaceutical products based on the microbiome
MetaboGen has been granted 4.9 MSEK by Sweden´s Innovation Agency, VINNOVA, for development of production- and formulation technologies (...) Read the full story
Jens Nielsen receives prestigious prize from ENI
MetaboGen founder Jens Nielsen is honored by ENI for research on the production of fuels from renewables
(...) Read the full storyFredrik Bäckhed is granted SEK 43 million from Knut and Alice Wallenberg Foundation
MetaboGen founder Fredrik Bäckhed is granted SEK 43 million over five years for his project "Transforming microbiome research"
(...) Read the full storyMetaboGen at the 4th microbiome R&D and business collaboration forum in Amsterdam
MetaboGen is attending the 4th microbiome R&D and business collaboration forum & probiotics congress in Amsterdam on April 3-4.
Mee (...) Read the full story